about
Cloning and expression of the histo-blood group Pk UDP-galactose: Ga1beta-4G1cbeta1-cer alpha1, 4-galactosyltransferase. Molecular genetic basis of the p phenotypeMolecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipidsStructural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin ITargeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxinsThe blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle.Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells: implication in the sensitivity to verotoxins.A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax are necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells.TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1.High expression of MDM2 protein and low rate of p21(WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced lymphoproliferation.Histo-blood group p: biosynthesis of globoseries glycolipids in EBV-transformed B cell lines.Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.Antitumor activity against L1210 mouse leukemia of immunotoxins containing a monoclonal antibody to the glycolipid globotriaosylceramide.Analysis of phenotypic and functional changes during ganglioside-induced inhibition of human T cell proliferation.Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products.New Interactors of the Truncated EBNA-LP Protein Identified by Mass Spectrometry in P3HR1 Burkitt's Lymphoma Cells.Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal.Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A.Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells.Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ.Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.Effect of Environmental Factors on Nuclear Organization and Transformation of Human B Lymphocytes.Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotidesCD77Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cellsHigh Concentration of the EBV Latent Membrane Protein 1 in Glycosphingolipid-Rich Complexes from both Epithelial and Lymphoid CellsDifferential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines
P50
Q22253436-B336E826-F76A-49C3-A00F-E83C7409DAFEQ22253437-FE2DD352-F93D-410A-8B63-C2F03BFE8518Q27651903-33E13D38-B2B8-41E9-B988-6F063085CBE4Q28592771-2B17C0F8-0065-4710-862B-0C9F3D597B6FQ33338583-1F7D9F0B-CF87-4210-B5AF-5CCA3F01F772Q33340534-DC497351-CF8E-4102-BF46-103A40FBD879Q36596569-F0D829F2-A817-4A2C-A0ED-9FFAA34D207AQ36735905-B681A78F-8755-4B7E-B31F-C17598F3157AQ38798819-87DC0551-78A0-45C8-9478-8E19A350CFF1Q38819714-0DCC282F-FB39-4699-8D87-451340D6BD3FQ38952194-AD8E39B4-137A-47FE-ABD2-80962B94B127Q39031743-D1583A9C-1BED-46B1-9401-E8387205B666Q39778110-D8674B60-838B-497E-AF7F-AEC8CA71395CQ39855621-13E30C38-D927-4A71-A793-BAC069F6B73EQ40134384-076167C5-5655-46ED-B748-DBCF1961C4AFQ40271342-E8C857A4-6D51-49F3-8DD9-A06C9DFFCC71Q40512215-5541738B-95D7-481C-8B04-1C3F4467B3FEQ40639628-A33107FD-9C21-4B43-AA47-6104F8011F79Q40928481-A9B08468-91BD-4CFB-BC07-D323DFE5B404Q41178230-82273F5F-00C1-4794-B99F-E2CF59A823B6Q41382152-6EAF7FAA-5CC8-4AD6-9462-5B5F7A3DC273Q41517521-50FFB7AD-851E-4CE6-BF08-C8D2C11F69BAQ41914406-CC439B4F-12CD-4539-B2A5-3C514B1223C2Q44163486-10897A17-D7FE-4562-AFC4-EFED3EDBE09BQ45841225-934942FE-B5E5-4EB4-9641-4E7353D90151Q46633795-9A96B7A2-F142-4FBC-9F1A-98279B13B780Q47230122-8B420716-2FF5-45CA-B73A-95096B3F7492Q47374141-631B433D-0026-4B3D-9286-CAD9CB48FB19Q49915776-B7ADC03D-3ADC-4C90-97B6-7915E843EADCQ50025664-0B861217-AD78-4D47-BD08-D93AEC03BB9EQ52264666-1E38E4B1-10EE-4D13-B91B-20A2A9C8BCD9Q52747879-4206EDBA-E447-4292-89E3-A205DD2D264EQ53467856-332CD240-C01B-479C-A886-5E96B9BC8782Q53988537-A1522932-4C59-49D1-AD3B-BA55114E474CQ54240145-1C5C1CF4-3101-4594-80DA-D67F6D85C8C3Q56917381-5EF83709-C59C-418D-A1D8-EB7112C40554Q56917388-ED7F7D8E-72DA-4047-BE51-7F5C5E3D1AAEQ56917403-B54771CB-75D5-4F2D-8A81-477861166B01Q56917409-FDD5195C-3E1E-4C17-B981-9CEC9FAE4C41Q56917416-B2D36AEA-903C-4A5D-BFFE-C80935C2C337
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joëlle Wiels
@de
Joëlle Wiels
@en
Joëlle Wiels
@es
Joëlle Wiels
@fr
Joëlle Wiels
@nl
Joëlle Wiels
@sl
type
label
Joëlle Wiels
@de
Joëlle Wiels
@en
Joëlle Wiels
@es
Joëlle Wiels
@fr
Joëlle Wiels
@nl
Joëlle Wiels
@sl
altLabel
J Wiels
@en
prefLabel
Joëlle Wiels
@de
Joëlle Wiels
@en
Joëlle Wiels
@es
Joëlle Wiels
@fr
Joëlle Wiels
@nl
Joëlle Wiels
@sl
P214
P244
P2732
P106
P21
P214
P244
n2016015588
P2732
P31
P496
0000-0002-3313-2937
P735
P7859
lccn-n2016015588